Michael York

40 papers receiving 2.5k citations

Michael York's Hit Papers

Fresolimumab treatment decreases biomarkers and improves clinical symptoms in systemic sclerosis patients 2015 · 265 citations
2650+3+7Years since publication50100150200250

Peers

Michael York
Comparison fields: 5 of 124
  • Small Animals 396
  • Dermatology 447
  • Pathology and Forensic Medicine 810
  • Immunology 628
  • Pharmaceutical Science 166
Replace John T. Lear with:
John T. Lear United Kingdom
Evangelia Papadavid Greece
Menno A. de Rie Netherlands
Kirk D. Wuepper United States
Elena Campione Italy
A. Anstey United Kingdom
Percy Lehmann Germany
P.E. Hutchinson United Kingdom
Nicola Cirillo Australia
Fleurette Abreo United States
Michael York relative to John T. Lear United Kingdom John T. Lear's profile →
Citations per field
00.5×4.6×
John T. Lear · 1×
Citations per year

Countries citing papers authored by Michael York

Since Specialization
Citations

This map shows the geographic impact of Michael York's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael York with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael York more than expected).

Fields of papers citing papers by Michael York

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael York. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael York. The network helps show where Michael York may publish in the future.

Co-authors

The 25 scholars most cited alongside Michael York, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Michael York Line = papers co-authored together Michael York links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 40 papers — load more, or switch the sort, to bring in the rest.

#Work
1 1997466
2
Fresolimumab treatment decreases biomarkers and improves clinical symptoms in systemic sclerosis patients
Hit paper breakdown →
2015265
3 2007235
4 2009214
5 2010109
6 1981103
7 199780
8 199678
9 201378
10
Recent diuretic use and the risk of recurrent gout attacks: the online case-crossover gout study.
200678
11 200477
12 199875
13 200061
14 200960
15 201759
16 199753
17 201052
18 199646
19 199944
20 199443

About Michael York

Michael York is a scholar working on Small Animals, Pathology and Forensic Medicine, Rheumatology, Dermatology and Immunology, having authored 40 papers that have together received 2.6k indexed citations. Recurring topics across this work include Animal testing and alternatives (14 papers), Systemic Sclerosis and Related Diseases (13 papers), Systemic Lupus Erythematosus Research (6 papers), Eosinophilic Disorders and Syndromes (4 papers), Advancements in Transdermal Drug Delivery (4 papers), Contact Dermatitis and Allergies (4 papers), Autoimmune Bullous Skin Diseases (3 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (3 papers). The work is most often cited by research in Small Animals (396 citations), Dermatology (447 citations), Pathology and Forensic Medicine (810 citations), Immunology (628 citations) and Pharmaceutical Science (166 citations). Michael York has collaborated with scholars based in United States, United Kingdom and Netherlands. Frequent co-authors include Robert Lafyatis, David A. Basketter, Giuseppina Farina, Robert W. Simms, H. A. Griffiths, Robert S. Lawrence, Jean Maguire van Seventer, Taro Nagai, Raphaël Lemaire and W. Steiling. Their work appears in journals such as Food and Chemical Toxicology, Annals of the Rheumatic Diseases, Contact Dermatitis, Journal of Investigative Dermatology and Toxicology in Vitro.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact